Moderna Inc. lashed out at the US Food and Drug Administration for making it harder for companies to create new medicines, ...
Moderna will report its fourth-quarter 2025 earnings this morning in an investor call that’s taken on even more interest in ...
Mani Foroohar, M.D., of Leerink Partners, says that the decision reflects “how sharp the departure has been between the prior ...
The biotech company said the FDA won’t review its flu vaccine, in the latest hit to mRNA development.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results